Home > Insider Trading > Filing (0001567619-18-000122)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366008	Sheldon Wang	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2018-08-06	5,107	$12.13	38,782	No	4	M	Direct
Class A Common Stock	Acquisiton	2018-08-06	20,000	$4.95	58,782	No	4	M	Direct
Class A Common Stock	Acquisiton	2018-08-06	5,039	$6.77	63,821	No	4	M	Direct
Class A Common Stock	Disposition	2018-08-06	4,459	$43.75	59,362	No	4	D	Direct
Class A Common Stock	Disposition	2018-08-06	6,593	$43.33	52,769	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Appreciation Rights	Disposition	2018-08-06	5,107	$0.00	5,107	$12.13
Class A Common Stock	Stock Appreciation Rights	Disposition	2018-08-06	5,039	$0.00	5,039	$6.77
Class A Common Stock	Stock Appreciation Rights	Disposition	2018-08-06	20,000	$0.00	20,000	$4.95

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2021-07-14	No	4	M	Direct
2021-05-25	No	4	M	Direct
2022-07-01	No	4	M	Direct

Footnotes

Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.